Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

According the result of the key study (Klimisch 1, GLP, OECD guideline 429 method followed), the registered substance 4 -amino-m-cresol induced delayed contact hypersensibility on LLNA Local Lymph Node Assay and EC3 values were calculated for DMSO vehicle, as 1.45% and for aqua/acetone/oil vehicle as 2.15%. According to the CLP regulation and criteria, the registered substance was classified as Category 1A for sensitizing effect.

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

The key study was performed to assess the skin sensitization potential of 4-amino-m-cresol by following the OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)(GLP compliant study, Klimisch 1). A total of 55 Female CBA/J mice of 10 week age. 25 μL of 0 (vehicle only), 0.5, 1.5, 5 and 10 % of 4-amino-m-cresol in DMSO and 0.5, 1.5, 3 and 5 % in a mixture of aqua/acetone (1:1) with olive oil (3:1) (equal to the maximum solubility) were applied to the surface of the ear to each of five female CBA/J mice per group for three consecutive days.. p-Phenylenediamine (PPD) at 1 % in DMSO was used as the positive control in parallel under identical test conditions. Animals were checked for morbidity/mortality at least once daily. Observation for clinical signs was done daily before and at least once after dosing. Body weight was determined on Day -2 and on Day 5.On Day 5, the mice received an intravenous injection of 250 μL phosphate buffered saline containing 23.6 μCi of [H3] methyl thymidine. Approximately 5 hours later, the mice were and the draining auricular lymph nodes were removed and weighed. After preparing a single cell suspension for each mouse, cells were precipitated by TCA and the radioactivity was determined (incorporation of [H3] methyl thymidine in the pellets) by means of liquid scintillation counting as disintegration per minute (dpm).

Lymph node weights were increased after treatment with 4-amino-m-cresol as compared to the vehicle controls indicating an immune response in both vehicles. The mean stimulation indices were affected in a dose-dependent manner by the treatment with 4-amino-m-cresol. With the test substance in DMSO, mean stimulation indices of 0.9, 3.1, 6.5 and 6.7 were obtained for the 4 test concentrations of 0.5, 1.5, 5 and 10 %, respectively. An EC3 value (equal to the concentration inducing a stimulation index of 3) of 1.45 % was calculated. In the second vehicle (aqua/acetone/olive oil), the indices were 1.5, 1.7, 4.7 and 6.9 for the 4 test concentrations of 0.5, 1.5, 3 and 5 %, respectively. An EC3 value of 2.15 % was calculated from these findings.

4-amino-m-cresol induced a biologically relevant immune response in local lymph nodes after dermal application to the mouse ear with either vehicle (DMSO or aqua/acetone/olive oil ) used. EC3 values of 1.45 % and 2.15 % were calculated for DMSO and aqua/acetone/olive oil, respectively. The concurrent positive control demonstrated the sensitivity of the assay.

Justification for classification or non-classification

According to the result of the key study (Klimisch 1, GLP, OECD guideline 429 method followed), the registered substance 4 -amino-m-cresol induced delayed contact hypersensibility on LLNA Local Lymph Node Assay and EC3 values were calculated for DMSO vehicle, as 1.45% and for aqua/acetone/oil vehicle as 2.15%. According to the CLP regulation and criteria, the registered substance was classified as Category 1A for sensitizing effect.